| An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion A Sánchez‐Salinas, V Cabañas‐Perianes, M Blanquer, MJ Majado, ... Transfusion 52 (11), 2382-2386, 2012 | 46 | 2012 |
| Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma R Alonso, MT Cedena, A Gómez‐Grande, R Ríos, JM Moraleda, ... American journal of hematology 94 (8), 853-861, 2019 | 40 | 2019 |
| Isolation and characterization of mesenchymal stem cells from the fat layer on the density gradient separated bone marrow CL Insausti, M Blanquer Blanquer, L Meseguer Olmo, MC López-Martínez, ... Stem cells and Development 21 (2), 260-272, 2012 | 35 | 2012 |
| Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA … A Oliver-Caldés, V González-Calle, V Cabañas, M Español-Rego, ... The Lancet Oncology 24 (8), 913-924, 2023 | 28 | 2023 |
| Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? A Jiménez-Ubieto, B Paiva, N Puig, MT Cedena, J Martínez-López, ... Blood, The Journal of the American Society of Hematology 138 (19), 1901-1905, 2021 | 27* | 2021 |
| Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis N Puig, B Paiva, M Lasa, L Burgos, JJ Perez, J Merino, C Moreno, ... Leukemia 33 (5), 1256-1267, 2019 | 25 | 2019 |
| Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing MV Martínez-Sánchez, A Periago, I Legaz, L Gimeno, A Mrowiec, ... Oncoimmunology 5 (4), e1093721, 2016 | 25 | 2016 |
| Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma N Puig, MT Contreras, C Agulló, J Martínez-López, A Oriol, MJ Blanchard, ... Blood advances 6 (11), 3234-3239, 2022 | 22 | 2022 |
| Assessment of biodistribution using mesenchymal stromal cells: Algorithm for study design and challenges in detection methodologies B Reyes, MI Coca, M Codinach, MD López-Lucas, A del Mazo-Barbara, ... Cytotherapy 19 (9), 1060-1069, 2017 | 21 | 2017 |
| Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development D Alameda, I Goicoechea, M Vicari, E Arriazu, A Nevone, S Rodriguez, ... Blood, The Journal of the American Society of Hematology 138 (17), 1583-1589, 2021 | 20 | 2021 |
| Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma R Termini, D Žihala, E Terpos, A Perez-Montaña, T Jelínek, M Raab, ... Clinical Cancer Research 28 (21), 4771-4781, 2022 | 16 | 2022 |
| Circulating aberrant plasma cells allows risk stratification of patients with myeloma. A Periago, JA Campillo, A Mrowiec, L Gimeno, NR Montes, ... American journal of hematology 91 (9), E353-E355, 2016 | 15 | 2016 |
| Blood-based risk stratification for pre-malignant and symptomatic plasma cell neoplasms to improve patient management MA Vasco-Mogorrón, JA Campillo, A Periago, V Cabañas, M Berenguer, ... American Journal of Cancer Research 11 (6), 2736, 2021 | 13 | 2021 |
| Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis I Cuenca, D Alameda, B Sanchez-Vega, D Gomez-Sanchez, D Alignani, ... Leukemia 35 (1), 245-249, 2021 | 13 | 2021 |
| Actualización en anemias hemolíticas M Berenguer Piqueras, V Cabañas Perianes, M Moya Arnao, ... Medicine. Programa de Formación Médica Continuada Acreditado 12 (20), 1148-58, 2016 | 13 | 2016 |
| Management multiple myeloma during pregnancy: a case report and review V Cabañas‐Perianes, M Macizo, E Salido, M Blanquer, F Araico, ... Hematological oncology 34 (2), 108-114, 2016 | 13 | 2016 |
| Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment A Minguela, MA Vasco-Mogorrón, JA Campillo, V Cabañas, MJ Remigia, ... American Journal of Cancer Research 11 (9), 4438, 2021 | 12 | 2021 |
| Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease JJ Lahuerta, A Jiménez-Ubieto, B Paiva, J Martínez-López, ... Blood, The Journal of the American Society of Hematology 133 (25), 2664-2668, 2019 | 12 | 2019 |
| Síndrome anémico A Sánchez Salinas, AM García Hernández, A Martínez Marín, ... Medicine: Programa de Formación Médica Continuada Acreditado 12 (20), 1127-35, 2016 | 12 | 2016 |
| Results from a pilot study of ARI0002h, an academic BCMA-directed CAR-T cell therapy with fractionated initial infusion and booster dose in patients with relapsed and/or … CF de Larrea, V Gonzalez-Calle, V Cabañas, A Oliver-Caldes, ... Blood 138, 2837, 2021 | 9 | 2021 |
